Anacor, Pfizer deal

Pfizer will acquire Anacor for $99.25 per share in cash, or about $5.2 billion net of cash. The price is a 55% premium to Anacor’s close of $64.03 on May 13, before the deal was announced. Anacor’s crisaborole ( AN2728) is under FDA review to treat mild to moderate atopic dermatitis in children and adults; the PDUFA date is Jan. 7, 2017. ...